Patient-friendly, non-technical summary of research papers

April 2026 Research Update

This report covers research on Eosinophilic fasciitis published in PubMed in April 2026. For other months, see all research updates.

Last update: May 19, 2026

At a glance

Topical tofacitinib + UVA-1
In one case report, topical tofacitinib combined with UVA-1 phototherapy was followed by clinical remission.
Worsened on standard medicines
In this report, skin plaques continued to worsen despite systemic corticosteroids and methotrexate.
Tolerability in one person
The combination was described as well tolerated in this single patient.
Single-case evidence
Because this is one case, it is still unclear how durable the response is and which patients might benefit.

Overview

This month’s research update was small and focused. It centered on one patient report about a skin-directed approach for eosinophilic fasciitis.

The report described an adolescent with eosinophilic fasciitis and morphea. Skin plaques kept worsening even with standard whole-body treatments like systemic corticosteroids and methotrexate.

After a topical form of tofacitinib (an anti-inflammatory medicine) was combined with UVA-1 phototherapy (a light-based treatment), the patient reached clinical remission. The combination was described as well tolerated in this one person.

The main meaning is that a topical medicine plus light treatment is a possible research direction for hard-to-treat disease. The evidence is still very early because it comes from a single case. Key open questions include who might benefit and how long remission might last.

Get the monthly update by email

Subscribe here to receive an email when a new monthly eosinophilic fasciitis update is published. You can unsubscribe at any time. Your address is used for this only; delivery is handled by MailerLite (privacy policy).

Research topics this month

Limitations

  • The month’s evidence was limited to a single case report.
  • The report did not clarify how long the remission lasted.
  • It remains uncertain which patients might benefit most from this approach.

Important information

  • This document summarizes recent research from PubMed-indexed publications using automated methods.
  • It is intended for educational purposes and does not replace medical advice.
  • Links to the original studies are provided via PubMed, where readers can explore abstracts and, when available, access full-text articles.
  • Some studies may include additional details that were not accessible for this summary.
  • Readers seeking more complete detail or context may find it helpful to review the original studies directly.